Ozempic Superior in Lowering Blood Sugar and Weight Vs Placebo, Both in Combination with SGLT-2 Inhibitors (2)

1) ZinmanB,et al. Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial.The Lancet Diabetes and Endocrinology.2019.ePubahead of print. DOI: https://doi.org/10.1016/S2213-8587(19)30066-X. 2) EMA. Ozempic(R)Summary of Product Characteristics. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_... 004174/WC500244163.pdf. Last accessed: March 2019. 3) FDA. Ozempic(R)US Prescribing Information. December 2017. Available at: http://www.novo-pi.com/ozempic.pdf.Lastaccessed: March 2019. 4) Novo Nordisk. Ozempic(R)approved in Japan for the treatment of type2 diabetes. Available at: https://www.novonordisk.com/content/Denmark/HQ/www-novonordi... ws-details.2178681.html. Last accessed: March 2019. 5) Novo Nordisk. Ozempic(R)approved in Canada for the treatment of adults with type2 diabetes. Available at: http://www.novonordisk.ca/content/dam/Canada/AFFILIATE/www-n... %20press%20release_Eng_01.08.2018_FINAL.pdf.Lastaccessed: March 2019. 6) Novo Nordisk. Company Announcement. Ozempic(R)(semaglutide) approved in the US. Available from: https://www.novonordisk.com/content/Denmark/HQ/www-novonordi... ws-details.2154210.html. Last accessed: March 2019. 7) Novo Nordisk. Ozempic(R)(semaglutide) recommended for approval by the European regulatory authorities. Available at: https://www.novonordisk.com/content/Denmark/HQ/www-novonordi... ws-details.2156392.html. Last accessed: March 2019. 8) Ozempic(R)(semaglutide) Brazil letter of marketing authorisation. August 2018. 9) Swissmedic. Ozempic(R)(semaglutide) approval. July 2018. Available at: https://www.swissmedic.ch/swissmedic/en/... ed-medicinal-products-with-new-active-substances/semaglutidum.html. Last accessed: March 2019.